Article
Integration of Real-World Data and Genetics to Support Target Identification and Validation.
Clinical pharmacology and therapeutics - 1 Jan 2022
Davitte Jonathan M, Stott-Miller Marni, Ehm Margaret G, Cunnington Marianne C, Reynolds Robert F
Abstract excerpt
Even modest improvements in the probability of success of selecting drug targets which are ultimately approved can substantially reduce the costs of research and development. Drug targets with human genetic evidence of disease association are twice as likely to lead to approved drugs. A key enabler of identifying and validating these genetically validated targets is access to association results from genome-wide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
